Indirect calorimetry: The 6 main issues.


Journal

Clinical nutrition (Edinburgh, Scotland)
ISSN: 1532-1983
Titre abrégé: Clin Nutr
Pays: England
ID NLM: 8309603

Informations de publication

Date de publication:
01 2021
Historique:
received: 22 01 2020
revised: 17 06 2020
accepted: 18 06 2020
pubmed: 28 7 2020
medline: 18 8 2021
entrez: 26 7 2020
Statut: ppublish

Résumé

Optimal nutritional therapy, including the individually adapted provision of energy, is associated with better clinical outcomes. Indirect calorimetry is the best tool to measure and monitor energy expenditure and hence optimize the energy prescription. Similarly to other medical techniques, indications and contra-indications must be acknowledged to optimise the use of indirect calorimetry in clinical routine. Measurements should be repeated to enable adaptation to the clinical evolution, as energy expenditure may change substantially. This review aims at providing clinicians with the knowledge to routinely use indirect calorimetry and interpret the results. We performed a bibliographic research of publications referenced in PubMed using the following terms: "indirect calorimetry", "energy expenditure", "resting energy expenditure", "VCO We have gathered the knowledge required for routine use of indirect calorimetry in clinical practice and interpretation of the results. A few clinical cases illustrate the decision-making process around its application for prescription, and individual optimisation of nutritional therapy. We also describe the latest technical innovations and the results of tailoring nutrition therapy according to the measured energy expenditure in medico-economic benefits. The routine use of indirect calorimetry should be encouraged as a strategy to optimize nutrition care.

Sections du résumé

BACKGROUND AND AIMS
Optimal nutritional therapy, including the individually adapted provision of energy, is associated with better clinical outcomes. Indirect calorimetry is the best tool to measure and monitor energy expenditure and hence optimize the energy prescription. Similarly to other medical techniques, indications and contra-indications must be acknowledged to optimise the use of indirect calorimetry in clinical routine. Measurements should be repeated to enable adaptation to the clinical evolution, as energy expenditure may change substantially. This review aims at providing clinicians with the knowledge to routinely use indirect calorimetry and interpret the results.
METHOD
We performed a bibliographic research of publications referenced in PubMed using the following terms: "indirect calorimetry", "energy expenditure", "resting energy expenditure", "VCO
RESULTS
We have gathered the knowledge required for routine use of indirect calorimetry in clinical practice and interpretation of the results. A few clinical cases illustrate the decision-making process around its application for prescription, and individual optimisation of nutritional therapy. We also describe the latest technical innovations and the results of tailoring nutrition therapy according to the measured energy expenditure in medico-economic benefits.
CONCLUSION
The routine use of indirect calorimetry should be encouraged as a strategy to optimize nutrition care.

Identifiants

pubmed: 32709554
pii: S0261-5614(20)30335-6
doi: 10.1016/j.clnu.2020.06.024
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

4-14

Informations de copyright

Copyright © 2020 Elsevier Ltd and European Society for Clinical Nutrition and Metabolism. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of interest All the coauthors have contributed to the development and validation of the new indirect calorimeter (Q-NRG) in collaboration with the manufacturer, but independently in terms of financial support (see above). All coauthors have a major motivation to promote calorimetry for clinical and research activities as they consider IC has a corner stone for optimal nutrition, but they do not have commercial interest or receive personal benefits for this action.

Auteurs

Najate Achamrah (N)

Nutrition Department, Rouen University Hospital Center, Rouen, France; Normandie Univ, URN, INSERM UMR 1073, Nutrition, Inflammation et dysfonction de l'axe Intestin-Cerveau, IRIB, Rouen, France. Electronic address: najate.achamrah@chu-rouen.fr.

Marta Delsoglio (M)

Clinical Nutrition, Geneva University Hospital, Geneva, Switzerland.

Elisabeth De Waele (E)

Nutrition Department, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussel, Belgium; Intensive Care Department, Universitair Ziekenhuis Brussel, Vrije Universiteit Brussels, Belgium.

Mette M Berger (MM)

Service of Adult Intensive Care and Burn, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Claude Pichard (C)

Clinical Nutrition, Geneva University Hospital, Geneva, Switzerland.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH